Mark Alan Smith - 30 Jun 2022 Form 4 Insider Report for VistaGen Therapeutics, Inc. (VTGN)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ Jerrold D. Dotson, Attorney-in-Fact
Issuer symbol
VTGN
Transactions as of
30 Jun 2022
Net transactions value
+$3,740
Form type
4
Filing time
15 Jul 2022, 16:30:27 UTC
Previous filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VTGN Common Stock Award $3,740 +5,000 +34% $0.7480* 19,915 30 Jun 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)